Randomised Phase II Study in Metastatic Pancreatic Cancer Evaluating FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem in First-line
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Gemcitabine (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms PANOPTIMOX
- 20 Feb 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.
- 20 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 11 Feb 2015 New trial record